https://www.ampulmonary.com/copd/article/22977537/mepolizumab-reduces-systemic-corticosteroid-exposure-in-copd-patientsPulmonaryen2026-10-29T20:03:15.000ZMepolizumab reduces systemic corticosteroid exposure in COPD patientshttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/10/cortecosteroid.KECVoEDsv8.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/copd/article/22977535/study-reveals-bmis-limitations-in-predicting-copd-riskPulmonaryen2026-10-29T20:00:42.000ZStudy reveals BMI's limitations in predicting COPD riskhttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/10/bmi.9KP9O7xm7Y.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/pulmonary/article/22977532/hidden-immune-cell-unlocks-novel-treatment-approachPulmonaryen2026-10-29T19:35:10.000ZHidden immune cell unlocks novel treatment approachhttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/10/wehi-cancr-cell-news-800x477.0mjheBbZtt.jpg?auto=format%252Ccompress&q=70A tissue sample taken from a long survivor patient with small cell lung cancer (SCLC), showing gamma delta T cells (red) infiltrating the SCLC cells (white). Other immune cells are shown in green.https://www.ampulmonary.com/asthma/article/22977485/allergen-immunotherapy-offers-new-hope-for-asthmaPulmonaryen2026-10-29T14:58:00.000ZAllergy treatment shows promise in changing the course of asthmahttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/10/gettyimages-2192258017.B0EtHwRBo5.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/asthma/article/22977482/severe-asthma-comorbidities-managing-hidden-health-burdensPulmonaryen2026-10-29T14:51:29.000ZThe hidden burden of comorbidities in severe asthma carehttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/10/gettyimages-2211003513-converted.4mh6cKacj7.png?auto=format%252Ccompress&q=70